MLICM
TARO

Metropolitan Life Insurance Company (MetLife)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-449
Closed -$19K – 2275
2024
Q1 		$19K Hold
449
– – ﹤0.01% 1885
2023
Q4 		$18.8K Hold
449
– – ﹤0.01% 1945
2023
Q3 		$16.9K Hold
449
– – ﹤0.01% 1976
2023
Q2 		$17K Buy
+449
New +$14.1K ﹤0.01% 2017

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TARO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 449 shares — an estimated $19K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TARO in Q2 2023 and held it in 4 quarters. The position peaked at $19K in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 449 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $19K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Taro Pharmaceutical Industries Ltd. position peaked at $19K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.